Old MRP ₹133.1
MRP ₹124.78
₹99.82
₹12.48/Units
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
Voglistar GM1 Tablet is used to manage uncontrolled type 2 diabetes mellitus. It is highly useful when diet, exercise, and single or dual therapies fail. This antidiabetic combination works by stimulating insulin release, reducing glucose production, and slowing carbohydrate absorption. This comprehensive mechanism ensures healthy blood sugar levels are maintained, mitigating the risk of diabetic complications.
Voglistar GM 1 Tablet is a combination medicine used in the management of type 2 diabetes mellitus to achieve optimal glycemic control by stimulating insulin release and delaying carbohydrate absorption, making it particularly effective at controlling rapid post-meal blood sugar rises.
Swallow the tablet whole with a glass of water.
Do not crush or chew the tablet.
Always take this medicine with your meals to minimise gastrointestinal side effects.
Make sure you do not exceed the dose as recommended by your doctor.
Remember not to abruptly discontinue taking this medicine without consulting your doctor first.
Voglistar GM1 Tablet is taken orally.
Voglistar GM 1 Tablet may lead to hypoglycemia, nausea, vomiting, diarrhoea, abdominal pain, a metallic taste in the mouth, and vitamin B12 deficiency.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Voglistar GM1 Tablet. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are a couple of tips to help manage some common side effects:
Nausea and Vomiting: Try taking Voglistar GM1 Tablet with meals to potentially reduce these effects.
Diarrhoea: Consider taking the tablet after eating to help minimise this side effect.
Voglistar GM1 Tablet contains three active ingredients that contribute to its efficacy:
Glimepiride (1 mg): Glimepiride belongs to a class of medicines called sulfonylureas. It stimulates insulin secretion from the pancreatic beta cells, which are responsible for producing insulin in your body. This process enhances the body's ability to utilise glucose effectively.
Metformin (500 mg): Metformin is a biguanide that acts by reducing the production of glucose in the liver, delaying the absorption of glucose in the intestines and improving insulin sensitivity in muscles and other tissues. Due to its extended-release formulation, it maintains consistent medication levels in your body for better efficacy.
Voglibose (0.2 mg): Voglibose is an alpha-glucosidase inhibitor. It slows down the digestion of carbohydrates in your small intestine, which helps to prevent the blood glucose levels from spiking after meals.
Voglistar GM1 Tablet is contraindicated during pregnancy.
Voglistar GM1 Tablet is contraindicated for breastfeeding/lactating women.
Drinking alcohol while taking Voglistar GM1 Tablet can enhance the risk of lactic acidosis. It is best to avoid alcohol consumption while on this medication.
Caution is advised while taking Voglistar GM1 Tablet if you have mild to moderate liver impairment. It is not recommended for severe liver diseases. If you have liver problems, discuss them with your doctor before starting this medicine.
Caution is advised before using Voglistar GM1 Tablet if you have a history of any kidney problems. It is a good idea to consult your doctor before taking this medicine.
No specific precautions are required while using machines or driving while on Voglistar GM1 Tablet as it does not affect your ability to concentrate or react. However, individual responses may vary.
If you are allergic to sulfonylureas, metformin, or alpha-glucosidase inhibitors, Voglistar GM1 Tablet should not be taken.
Voglistar GM1 Tablet is not recommended for use in children. Always consult your doctor before giving any medicine to a child.
Older patients should take Voglistar GM1 Tablet under medical supervision, as they may be more susceptible to its side effects. Caution is advised if patients are above 70 years of age. Older patients might also have liver and kidney issues and might be on other medication. Your doctor will guide you based on your health status.
Voglistar GM1 Tablet interacts with the following medicines:
Thiazide Diuretics: These medications, like hydrochlorothiazide can reduce the blood sugar-lowering effect of Voglistar GM1 Tablet.
Beta-blockers: Medicines like atenolol may hide symptoms of low blood sugar.
ACE Inhibitors: These medications, such as lisinopril, can increase the risk of low blood sugar.
Voglistar GM1 Tablet interacts with the following diseases:
Type 1 Diabetes Mellitus or Diabetic Ketoacidosis: This medicine is not suitable, as it's designed to manage type 2 diabetes, not type 1 diabetes or associated ketoacidosis.
Metabolic Acidosis, including Lactic Acidosis: As lactic acidosis is a rare but serious side effect of metformin in Voglistar GM1 Tablet, patients with a history of metabolic acidosis should avoid this medication.
The daily dose of Voglistar GM1 Tablet should be taken as advised by your doctor. It can vary according to individual factors, such as how severe the condition is and how you respond to the medicine. Always adhere to the prescribed dosage and never exceed it without consulting your doctor.
An overdose of Voglistar GM1 Tablet could cause severe low blood sugar or increase acid levels in your blood. If this happens, it's important not to panic but to seek medical attention promptly.
If you forget to take your dose of Voglistar GM1 Tablet, take it as soon as you remember. However, if it's nearly time for your next dose, skip the one you missed and continue with your regular schedule. Don't increase your dosage without speaking to your doctor first.
Always store Voglistar GM1 Tablet in a cool, dry place, ideally below 30°C.
Keep the medicine out of direct sunlight and away from moisture.
Ensure the tablet is kept well out of reach of children.
Don't forget to use the medicine before its expiry date.
Follow a balanced diet that is low in carbohydrates and sugars.
Regular physical activity can also support blood sugar management. Aim for at least 30 minutes of moderate-intensity exercise, such as brisk walking or cycling, every day.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Type 2 diabetes mellitus |
| Drug Category | Sulfonylurea, Biguanide, Alpha-glucosidase Inhibitor |
| Therapeutic Category | Antidiabetic |
Voglistar GM1 Tablet is used to manage type 2 diabetes in adults by helping to control blood sugar levels.
It contains three active ingredients that work together to effectively use glucose, reduce glucose production in the liver, and slow down carbohydrate digestion.
Yes, but some medicines such as beta-blockers and ACE inhibitors may interact with Voglistar GM1 Tablet, altering their effectiveness or increasing the risk of side effects. Always consult your doctor.
Overdose can cause severe hypoglycaemia or lactic acidosis. Seek immediate medical attention if you have taken more than the recommended dose.
Common side effects include hypoglycaemia, nausea, vomiting, diarrhoea, abdominal pain, and a metallic taste in your mouth.
Voglistar GM1 Tablet is contraindicated during pregnancy and lactation. Always consult your doctor before starting any new medication.
Store it below 30°C in a cool, dry place. Protect from light and moisture and keep out of reach of children.
Check out Editorial Policy
Metformin: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB00331
Glimepiride: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB00222
Voglibose: uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB04878
Bantwal, G., Ayyar, V., Kovil, R., Chawla, M., Shah, T., Kumar, S., Abhyankar, M., & Revankar, S. (2021). Assessment of clinical experience of triple drug fixed-dose combination of glimepiride, metformin and voglibose in the management of Type 2 diabetes mellitus: a retrospective study. Journal of Clinical and Diagnostic Research. https://doi.org/10.7860/jcdr/2021/47919.15346
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
4421 users bought this instead
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.15.1
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
Composition
